-
Mashup Score: 1FDA Approves Avacopan to Treat ANCA-associated Vasculitis - 3 year(s) ago
The FDA has approved avacopan (Tavneos) as an adjunctive treatment for severe ANCA-associated vasculitis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2FDA Approves Avacopan to Treat ANCA-associated Vasculitis - 3 year(s) ago
The FDA has approved avacopan (Tavneos) as an adjunctive treatment for severe ANCA-associated vasculitis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Vasculitis Treatment Guidelines: What Rheumatologists Should Know - Docwire News - 3 year(s) ago
The American College of Rheumatology (ACR) and the Vasculitis Foundation released three new clinical practice guidelines for treating and managing
Source: Docwire NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Clinical Practice Guidelines Vasculitis - 3 year(s) ago
Read American College of Rheumatology clinical practice guidelines for the prevention and treatment of vasculitis.
Source: www.rheumatology.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification - 3 year(s) ago
Primary and secondary ANCA-negative pauci-immune necrotizing glomerulonephritis. Pauci-immune necrotizing glomerulonephritis (PING) is a small-vessel kidney vasculitis usually associated with the presence of anti-neutrophil cytoplasm antibodies (ANCA) directed against the myeloperoxidase or the proteinase 3. A minority of patients with PING do not have this type of ANCA. To describe the clinical…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0FDA Advisors Split on New Drug for Vasculitis - 3 year(s) ago
Concerns raised about study design and off-protocol use of steroids
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
A molecule released by platelets — cell fragments in the blood that form clots and stop or prevent bleeding — appears to contribute to the progression of ANCA-associated vasculitis (AAV) by triggering a defense mechanism carried out by white blood cells. Researchers now have identified a key…
Source: ANCA Vasculitis NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study - 3 year(s) ago
Background Small studies suggest an association between ANCA-associated vasculitis (AAV) incidence and rurality, seasonality and socioeconomic deprivation. We examined the incidence of kidney biopsy-proven AAV and its relationship with these factors in the adult Scottish population. Methods Using the Scottish Renal Biopsy Registry, all adult native kidney biopsies performed between 2014 and 2018…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0StR training series: Vasculitis - 3 year(s) ago
StR training series: Vasculitis
Source: www.rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 6Predicting relapse in ANCA-associated vasculitis: a systematic review and meta-analysis - 3 year(s) ago
AbstractObjectives. Relapses affect 30-50% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) over 5 years, necessitating lo
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet
The U.S. Food and Drug Administration approved avacopan #Tavneos for adult patients with severe active anti-neutrophil cytoplasmic autoantibody #ANCA -associated vasculitis. @US_FDA FDA US FDA News @FDAMedWatch @chemocentryxinc ChemoCentryx ChemoCentryx https://t.co/lFllsh3xvk